1980
DOI: 10.1016/s0140-6736(80)91883-8
|View full text |Cite
|
Sign up to set email alerts
|

Intrathecal Human Tetanus Immunoglobulin in Early Tetanus

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
18
0
1

Year Published

1983
1983
2013
2013

Publication Types

Select...
4
4

Relationship

0
8

Authors

Journals

citations
Cited by 67 publications
(25 citation statements)
references
References 6 publications
0
18
0
1
Order By: Relevance
“…El 27.7% de los pacientes inició su enfermedad con disfagia (con o sin trismos), pero a diferencia de los considerado por algunos autores (2), ésta no se asoció significativamente con cuadros severos de tétanos (Tabla N°6). Probablemente esto se deba a que la mayoría de pacientes presentan disfagia como consecuencia del trismos (13,14,20) pero el dato no siempre es indagado adecuadamente.…”
Section: Discussionunclassified
“…El 27.7% de los pacientes inició su enfermedad con disfagia (con o sin trismos), pero a diferencia de los considerado por algunos autores (2), ésta no se asoció significativamente con cuadros severos de tétanos (Tabla N°6). Probablemente esto se deba a que la mayoría de pacientes presentan disfagia como consecuencia del trismos (13,14,20) pero el dato no siempre es indagado adecuadamente.…”
Section: Discussionunclassified
“…The most frequently cited are duration of hospitalization, length of stay in the intensive care unit, the need for and the duration of respiratory assistance, frequency of complications, the clinical progression of the disease, the need for tracheotomy, and the sedative dose needed to control spasms, as well as lethality (1,8,16,19,(24)(25)(26)(27)(28)(29)(30).…”
Section: Discussionmentioning
confidence: 99%
“…Secondly, it may be a tool for the determination of the clinical condition of tetanus patients at a specific time independently of what is suggested by prognostic indicators. These classifications are usually based on clinical manifestations (2,(11)(12)(13)(14)(15)(16)(17)(18) D.B. Miranda- Filho et al and can be used to monitor the evolution of the disease after treatment has been initiated by comparing the classification established upon admission to reclassifications carried out throughout the hospital stay (16).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Extensive studies were done to determine the optimal dose of antitoxin and the possible benefit of intrathecal antitoxin, particularly in tetanus neonatorum, a common problem in developing countries (68). Since 1960, a human tetanus immune globulin (TIG) has been available in the United States, but in some areas of the world only equine antitoxin is available.…”
Section: Tetanusmentioning
confidence: 99%